China Health Group Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Health Group Inc with three other
miscellaneous service companies in Asia:
SanBio Co Ltd
sales of 949.54 million Japanese Yen [US$8.59 million]
of which 100%
was Commercial Physical Research),
(957.64 million Japanese Yen [US$8.67 million]
of which 54%
was Cell Therapy Technology Development Busi), and
Human Metabolome Technologies Inc
based in Japan
(914.18 million Japanese Yen [US$8.27 million]
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
China Health Group Inc were HK$67.70 million (US$8.63 million).
increase of 186.7%
versus 2016, when the company's sales were HK$23.61 million.